JACOBS LEVY EQUITY MANAGEMENT, INC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2023$15,108,944
-2.8%
177,460
-5.5%
0.09%
-8.4%
Q1 2023$15,547,318
-18.7%
187,883
-22.7%
0.10%
-26.4%
Q4 2022$19,121,624
+2.2%
243,123
-3.8%
0.13%
-12.8%
Q3 2022$18,715,000
+5.1%
252,805
-7.5%
0.15%
+7.2%
Q2 2022$17,813,000
+1178.8%
273,282
+1140.6%
0.14%
+1433.3%
Q1 2022$1,393,000
+136.5%
22,029
+329.4%
0.01%
+50.0%
Q4 2019$589,000
-31.9%
5,130
-25.2%
0.01%
-45.5%
Q3 2019$865,000
+54.2%
6,860
+47.2%
0.01%
+37.5%
Q2 2019$561,000
+100.4%
4,660
+45.6%
0.01%
+100.0%
Q1 2019$280,000
-61.5%
3,200
-56.0%
0.00%
-69.2%
Q4 2018$728,000
-22.6%
7,281
-11.2%
0.01%0.0%
Q3 2018$940,000
-81.2%
8,201
-85.3%
0.01%
-83.5%
Q2 2018$4,995,000
+16.0%
55,701
-5.4%
0.08%
+9.7%
Q1 2018$4,307,000
+1166.8%
58,871
+904.6%
0.07%
+1100.0%
Q4 2017$340,000
+29.3%
5,8600.0%0.01%
+20.0%
Q3 2017$263,000
-45.2%
5,860
-64.6%
0.01%
-50.0%
Q2 2016$480,000
-28.6%
16,550
-13.9%
0.01%
-28.6%
Q1 2016$672,000
-40.6%
19,212
-45.3%
0.01%
-36.4%
Q4 2015$1,132,000
+2.4%
35,112
+2.6%
0.02%
-4.3%
Q3 2015$1,106,00034,2320.02%
Other shareholders
HAEMONETICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders